MEGESTROL ACETATE IMPURITY B
Digestive System Cancer
Changchun GeneScience Pharmaceutical Co., Ltd.Small moleculeActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Digestive System Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Nano-Crystalline Megestrol Acetate Suspension Changchun GeneScience Pharmaceutical Co., Ltd. | D |
Same molecule, other indications
MEGESTROL ACETATE IMPURITY B is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →